Massive Increase, Spread, and Exchange of Extended Spectrum {beta}-Lactamase-Encoding Genes Among Intestinal Enterobacteriaceae in Hospitalized Children With Severe Acute Malnutrition in Niger. by Woerther, P-L et al.
MAJOR ARTICLE
Massive Increase, Spread, and Exchange of
Extended Spectrum b-Lactamase–Encoding
Genes Among Intestinal Enterobacteriaceae in
Hospitalized Children With Severe Acute
Malnutrition in Niger
Paul-Louis Woerther,1,2 Ce ´cile Angebault,1,2 Herve ´ Jacquier,3,5 Henri-Charles Hugede,1 Ann-Carole Janssens,4
Sani Sayadi,4 Assiya El Mniai,1 Laurence Armand-Lefe `vre,1,2 Etienne Ruppe ´,1,2 Franc xois Barbier,1,2 Laurent Raskine,5
Anne-Laure Page,4 Nathalie de Rekeneire,4 and Antoine Andremont1,2
1French National Reference Center for BacterialResistance in Commensal Flora, Laboratoryof Bacteriology, Bichat–Claude Bernard Hospital, Assistance
Publique–Ho ˆpitaux de Paris; 2EA3964, 3INSERM, UMR-S 722, and Universite ´ Paris Diderot, Sorbonne Paris Cite ´, Medical School, and 4Epicentre,
Me ´decins Sans Frontie `res, Paris; and 5Laboratory of Bacteriology, Lariboisie `re Hospital, Assistance Publique–Ho ˆpitaux de Paris, France
Background. From the time of CTX-M emergence, extended-spectrum b-lactamase–producing enterobacteria
(ESBL-E) have spread worldwide in community settings as well as in hospitals, particularly in developing countries.
Although their dissemination appears linked to Escherichia coli intestinal carriage, precise paths of this dynamic are
largely unknown.
Methods. Children from a pediatric renutrition center were prospectively enrolled in a fecal carriage study.
Antibiotic exposure was recorded. ESBL-E strains were isolated using selective media from fecal samples obtained at
admissionand, when negative, also at discharge. ESBL-encoding genes wereidentiﬁed,their environmentsand plasmids
w e r ec h a r a c t e r i z e d ,a n dc l o n a l i t yw a sa s s e s s e dw i t hp o l y m erase chain reaction–based methods and pulsed-ﬁeld gel
electrophoresis for E. coli and Klebsiella pneumoniae. E. coli strains were subjected to multilocus sequence typing.
Results. The ESBL-E carriage rate was 31% at admission in the 55 children enrolled. All children enrolled
received antibiotics during hospitalization. Among the ESBL-E–negative children, 16 were resampled at discharge,
and the acquisition rate was 94%. The blaCTX-M-15 gene was found in .90% of the carriers. Genetic environments
and plasmid characterization evidenced the roles of a worldwide, previously described, multidrug-resistant region
and of IncF plasmids in CTX-M-15 E. coli dissemination. Diversity of CTX-M-15–carrying genetic structures and
clonality of acquired ESBL E. coli suggested horizontal genetic transfer and underlined the potential of some ST
types for nosocomial cross-transmission.
Conclusions. Cross-transmission and high selective pressure lead to very high acquisition of ESBL-E carriage,
contributing to dissemination in the community. Strict hygiene measures as well as careful balancing of beneﬁt–risk
ratio of current antibiotic policies need to be reevaluated.
In developing countries, children who are hospitalized
for malnutrition are at high risk of dying of severe
bacterial infections [1–3]. Thus, the World Health Or-
ganization (WHO) recommends empiric systemic
broad-spectrum antibiotics, whenever they are suspect
of infection [4]. However, this can promote intestinal
colonization by multiresistant bacteria, especially gram-
negative bacilli [5, 6]. Recently, focus has been di-
rected on intestinal carriage by extended -spectrum
b-lactamase–producing enterobacteria (ESBL-E), be-
cause it is the primum movens for multidrug-resistant
bacterial infections, which leave few therapeutic op-
tions open, negatively affect outcome, and promote
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 resistance dissemination [7, 8]. Among ESBL, CTX-M are of
major concern because they have spread worldwide, in commu-
nity settings as well as in hospitals [9]. These plasmid-borne genes
impair efﬁcacy of all b-lactams except carbapenems and cepha-
mycins and are most often associat e dw i t hm u l t i p l e - a s s o c i a t e d
resistances. Intestinal colonization is the cornerstone of their
dissemination [9]. This may be the consequence of their prefer-
ential association with Escherichia coli, which is not only the main
enterobacteria of the human intestinal microbiota, but also
a facultative pathogen [10]. However, although E. coli may play
a reservoir role, plasmids carrying CTX-M enzymes can also
disseminate in other commensal enterobacteria, such as Klebsiella
pneumoniae, particularly in hospitals [11], or even to more
pathogenic species, such as Shigella[12]o rSalmonella[13].Sparse
data indicate that rates of ESBL–E. coli intestinal carriage are high
in African communities even when antibiotic pressure is low [14].
This shows their diffusion capacities in the community, whereas
ESBL–E. coli cross-transmission remains scarcely reported be-
tween hospitalized patients from developed countries [15].
However, the precise paths of this overall dynamic are largely
unknown. In this study, we evaluated prevalence of ESBL-E at
entry and the acquisition rate for ESBL-E in children with severe
acute malnutrition hospitalized in an intensive care unit (ICU)
of a renutrition center.
MATERIALS AND METHODS
Study Design
This work was a substudy of a general study on the prevalence of
infections among children with severe acute malnutrition that
was run by a large international nongovernmental organization
(Me ´decins Sans Frontie `res) and the results of which will be
published elsewhere. This general study took place between
November 2007 and July 2008 in a 300-bed pediatric renutrition
center located in Maradi (Niger). This center was composed of
a 60-bed ICU with 6 full-time nurses, a transition phase with 1
nurse for 20–30 children, and a nutritional rehabilitation phase
with 1 nurse for 40–50 children. Children were included in the
general study if they were 0.5–5 years old (60–110 cm in height)
with severe acute malnutrition (bilateral edema and/or mid-
upper arm circumference ,110mm, weight-for-height less than
3 z score of the median) and a severe medical condition [16].
They were also not referred from another health institution and
had not received antibiotics for at least 1 week according to their
parents. Informed consent to participate was obtained from
children’s parents. Every ﬁfth child included in the general study
was included in the intestinal carriage substudy, which is the
subject of this article.
Clinicaldatawererecordedatadmission.Recordsofvomiting
and diarrhea were based on the mother’s report. Fecal samples
were obtained for detection of ESBL-E (see below) at admission
and before discharge. Antibiotic policy in the ICU was based on
WHO recommendations, which includes a short course of
amoxicillin for all children with severe acute malnutrition [4].
This systematic antibiotic therapy was replaced by parenteral
ceftriaxone (100 mg/kg/day) when there was suspicion of severe
or complicated lower respiratory tract infection, meningitis, septic
shock, hypothermia, or diarrhea. Oral amoxicillin (80 mg/kg/day
for 5 days) was given to children with upper respiratory tract
infection, and clavulanate was added in those with treatment
failure. Oral ciproﬂoxacin (10–15 mg/kg/day) was available on
medical request. Antibiotic exposure for each child was deﬁned as
the total number of antibiotic treatment days divided by the
number of days of hospitalization. This study adhered to the
principles that govern biomedical research involving human
subjects [17] .E t h i c a la p p r o v a lw a sg r a n t e db yt h eE t h i c a lC o m -
mittee of Niger and the Conseil de Protection des Personnes,
S a i n t - G e r m a i ne nL a y e, France. Written informed consent was
obtained from the legal representatives of included children after
o r a la n dw r i t t e ni n f o r m a t i o nd e l i v e r e di nF r e n c ho ri nH a u s s a ,the
native language of the representatives.
Microbiology
T h ep r e v a l e n c eo fE S B L - Ec a r r i a g ea ta d m i s s i o nw a sm e a s u r e d
from fecal samples obtained within 24 hours of admission, and the
acquisition rate was measured from samples obtained at discharge
from the children who were free of ESBL-E at admission.
Aliquots (200 mg) of freshly passed stools were inoculated
by central puncture in conservation agar tubes (Bio-Rad) and
transported to France at room temperature. They were then
plated on ChromID ESBL agar plates (BioMe ´rieux) for de-
tection of ESBL-E and on Drigalski agar for control of viable
enterobacteria in the sample. All colonies with different
morphotypes on ESBL agar were identiﬁed to the species level
using standard techniques (API20E, Biome ´rieux). Antibiotic
susceptibility was determined using the agar diffusion
method, as recommended by the French Society for Micro-
biology (www.sfm-microbiologie.org). ESBL content was
characterized as described elsewhere [18]. Resistance genes,
including blaCTX-M, blaSHV,a n dblaTEM, were ampliﬁed with
speciﬁc primers according to phenotypic results, as
described elsewhere [18]. Finally, cephalosporinase blaCMY
genes were screened in E. coli or K. pneumoniae strains
expressing a cephalosporinase phenotype, using ad hoc primers
(AmpCU-F: 5#-GCARACSCTGTTYGAGMTDGG-3#;A m p C - R :
5#-CTCCCARCCYARYCCCTG-3#). Ampliﬁcation products
were sequenced and submitted to the National Center for Bio-
technology Information library for identiﬁcation (http://blast.
ncbi.nlm.nih.gov). The transferability of blaCTX-M-15 genes from
E. coli and K. pneumoniae strains was assessed by mating with
E. coli J53
rif, as described elsewhere [18]. When mating was
negative, transformation into E. coli TOP10 (Invitrogen) was
678 d CID 2011:53 (1 October) d Woerther et al
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 attempted by electroporation of whole plasmid DNA extracted,
as recommended by the manufacturer (Macherey Nagel).
Transformants were selected on Drigalski agar with 2 mg/L
cefotaxime.
CTX-M-15 E. coli ESBL strains were typed by repetitive ex-
tragenic palindromic polymerase chain reaction (rep-PCR), as
described elsewhere, and K. pneumoniae ones by enterobacterial
repetitive intergenic consensus (eric-PCR), also as described
elsewhere [19, 20]. Ampliﬁcation products were separated by
electrophoresis at 70 V for 3 hours on 1% agarose gel and
stained by SYBR Safe dye (Invitrogen). When identical E. coli
patterns were observed, representative strains were selected for
multilocus sequence typing (MLST), performed as recom-
mended (http://mlst.ucc.ie/). To maximize discrimination
among CTX-M-15 E. coli and K. pneumoniae strains, all strains
with similar PCR patterns were also typed by pulsed-ﬁeld gel
electrophoresis (PFGE) as well as acquired strains with a single
PCR pattern. Results were analyzed and interpreted, as de-
scribed elsewhere [21]. FII, FIA, FIB, I1/Ic, A/C, and L/M
plasmid replicons from parental E. coli and K. pneumoniae,a s
well as from transconjugants or transformants, were PCR ty-
ped, as described elsewhere [22, 23]. The genetic environment
of blaCTX-M-15 genes from E. coli and K. pneumoniae was
compared with that of pandemic plasmid pC15-1a, using E. coli
strain TN03 as a positive control, as described elsewhere [23].
Data Analysis
Characteristics of children included in the study were compared
withthose of theother children admittedto the ICU, withuse of
R software (version 2.12.1; http://www.cran.r-project.org).
Univariate comparison of discrete variables was performed us-
ing the 2-sided Pearson v
2 test and Fisher exact test; Student’s
t test and the Wilcoxon test were used for continuous variables.
Because of the large number of explanatory variables tested,
results of univariate analysis were adjusted using the Holm
adjustment for multiple testing [24, 25].
RESULTS
Patients and Samples
A total of 2567children were admitted directly to the renutrition
center during the study period. Three hundred eleven were in-
cluded in the general study, which will be described elsewhere.
Among these children, we included 55 (18%) in the intestinal
carriage study. The geographic origins of the children were di-
verse; only 12.5% came from the city of Maradi, 64.0% from
neighboring districts, and 23.5% from Nigeria. There were no
signiﬁcant differences in any characteristic, including antibiotic
exposure and geographic origin, between the children included
in the intestinal carriage study and the 256 other children in-
cluded in the general study (Table 1). Among the included
children, 92.7% had weight-for-height zscores , 23, conﬁrming
the high rate of severe malnutrition. Vomiting (41.8%), diarrhea
(50.9%), and axillary temperature .38C (47.3%) suggested the
high prevalence of acute bacterial infections (Table 1). Antibiotic
exposure was very high, with an exposure score of 0.96 treatment
days/hospitalization days. All children included in the intestinal
carriage study received antibiotic treatment during hospitaliza-
tion, and 74.5% received more than one type of antibiotic.
The ESBL-E carriage rate at admission in the 55 children in
the study was 30.9% (17/55). Five children were carrying 2
strains (Table 2), including 2 strains of E. coli in 1, E. coli plus
Enterobacter cloacae in 2, E. coli plus K. pneumoniae in 1, and
K. pneumoniae plus E. cloacae in 1. Thus, a total of 22 ESBL-E
strains were isolated, often coresistant to other antibiotics (data
not shown), including E. coli in 71% (12/17) of the children,
Enterobacter sp. in 29% (4/17 for E. cloacae and 1/17 for
Enterobacter asburiae), and K. pneumoniae in 24% (4/17). The
blaCTX-M-15 gene was present in 91% of the strains (20/22) when
blaSHV-2a and blaSHV-12 were found in 1 K. pneumoniae strain
each. The blaCTX-M-15 strains were diverse, except for 3 E. coli
strains isolated from 3 children admitted on 3 April, 29 April,
and 15 July, who shared the same PCR-based pattern (data not
shown). They were each from a distinct geographic area (data
notshown).Tenofthe13CTX-M-15–carryingplasmidsfromE.
coli (66%) were typable with 1 of 4 replicon combinations: FIA/
FIB (5 cases), FII/I1/Ic (3 cases), FII/FIA (1 case), and I1/Ic (1
case). Multidrug resistance (MDR) regions analogous to that of
the pandemic pC15-1a plasmid were found in 7 of 13 (54%) of
the CTX-M-15 E. coli strains isolated at admission, with minor
variation consisting of deletion of J5 junction (2 strains), J6
junction and blaTEM (1 strain), or tet(A) and J5 junction (1
strain). In addition, FIA/FIB multireplicons were present in 5 of
these 7 strains, suggesting that the MDR region was carried by
related plasmids. In contrast, the 2 CTX-M-15 K. pneumoniae
strains were MDR negative, and no marker of any plasmid in-
compatibility group was detected. MLST of the E. coli strains
identiﬁed 10 sequence types (types 354, 5, 131, 10, 101, 68, 448,
196, 410, and 361). Moreover, although isolated from 3 un-
related children from different geographic origins and at dif-
ferent dates, all 3 ST361 strains carried CTX-M-15, contained
the pC15-1a MDR, and had identical plasmid markers, sug-
gesting circulation of the clone in the community.
Acquisition Rate and Characteristics of Strains at Discharge
The acquisition rate of ESBL-E strains was calculated in 16
children in whom ﬁndings were negative at admission and
samples were obtained again at discharge (median, 8 days later;
range, 3–13 days later). It was as high as 94% (15/16 children).
Theantibioticexposureinthisgroupwasnotsigniﬁcantlyhigher
than in the other children included in the general study (1.00
treatment days/day of hospitalization [95% conﬁdence interval
Extended Spectrum b-Lactamase Carriage in a Renutrition Center d CID 2011:53 (1 October) d 679
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 Table 1. Characteristics of ICU Children Included or Not Included in the Intestinal Carriage Study
Characteristics
Inclusion in carriage study
Bivariate odds ratio (95% CI)
a P Adjusted P
b No (n 5 256) Yes (n 5 55)
Sociodemographic characteristics
Age, mean (range), months 17.04 (6–59) 16.25 (7–36) . .52 1.00
Female-male ratio 1.18 1.29 . .88 1.00
Characteristics at admission
Hospital stay, median (range), days 9 (1–49) 10 (2–40) . .27 1.00
Weight, mean (range), kg 6.0 (3.1–12.1) 6.2 (3.3–9.6) . .33 1.00
Height, mean (range), cm 70.54 (60.0–97.0) 70.65 (60.5–82.5) . .91 1.00
Weight-for-height z score
$22 6 (2.4) 1 (1.8 1.0 .46 1.00
,22 7 (2.7) 3 (5.5) 2.4 (0.1–156.9)
,23 242 (94.9) 51 (92.7) 1.3 (0.1–59.3)
Edema 37 (14.5) 11 (20.0) 1.5 (0.6–3.2) .31 1.00
Axillary temperature .38C 116 (45.3) 26 (47.3) 1.1 (0.6–2.0) .88 1.00
Dehydration
None 202 (78.9) 49 (89.1) 1.0 .29 1.00
Moderate 44 (17.2) 5 (9.1) 0.5 (0.1–1.3)
Severe 10 (3.9) 1 (1.8) 0.4 (0.0–3.0)
Diarrhea 149 (58.2) 28 (50.9) 0.7 (0.4–1.4) .37 1.00
Vomiting 113 (44.1) 23 (41.8) 0.9 (0.5–1.7) .77 1.00
Outcome and antibiotic treatment
Death 23 (9.0) 6 (10.9) 1.2 (0.4–3.4) .61 1.00
Antibiotic exposure (cumulative
treatment days/days in hospital)
(range)
0.93 (0.1–3.2) 0.96 (0–2.5) .66 1.00
No. of antibiotics received
1 113 (44.3) 14 (25.5) 1.0 .05 .95
2 90 (35.3) 28 (50.9) 2.5 (1.2–5.5)
3 38 (14.9) 9 (16.4) 1.9 (0.7–5.2)
4 14 (5.5) 4 (7.3) 2.3 (0.5–8.8)
Treatment duration, days
Any antibiotic
c
0 1 (0.4) 0 (0.0) . .32 1.00
1–3 26 (10.2) 4 (7.3) 1.0
4–8 125 (48.8) 21 (38.2) 1.1 (0.3–4.7)
$9 104 (40.6) 30 (54.5) 1.9 (0.6–7.9)
Ceftriaxone
0 63 (24.6) 12 (21.8) 1.0 .87 1.00
1–3 31 (12.1) 6 (10.9) 1.0 (0.3–3.3)
4–8 130 (50.8) 28 (50.9) 1.1 (0.5–2.6)
$9 32 (12.5) 9 (16.4) 1.5 (0.5–4.3)
Cloxacillin
0 214 (83.6) 45 (81.8) 1.0 .92 1.00
1–3 11 (4.3) 2 (3.6) 0.9 (0.1–4.2)
4–8 20 (7.8) 5 (9.1) 1.2 (0.3–3.5)
$9 11 (4.3) 3 (5.5) 1.3 (0.2–5.2)
Amoxicillin
0 165 (64.5) 25 (45.5) 1.0 .05 1.00
1–3 54 (21.1) 19 (34.5) 2.3 (1.1–4.8)
4–8 35 (13.7) 11 (20.0) 2.1 (0.8–4.9)
$9 2 (0.8) 0 (0.0) 0.0 (0.0–36.1)
680 d CID 2011:53 (1 October) d Woerther et al
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 (CI), 0.12–1.27] vs 0.86 [95% CI, 0.33–2.50]) (data not shown).
Acquired strains consist of 39 ESBL-E strains (2.3/colonized
child; range, 1–4), including 19 E. coli,1 1K. pneumoniae,
5 E. cloacae, and 4 Salmonella Typhimurium strains (Table 2).
Acquisition rates were 94% (15/16), 69% (11/16), 31% (5/16)
and 25% (4/16) for each species, respectively. Ninety percent of
these strains (35/39) produced CTX-M-15 (17 E. coli,1 0K.
pneumoniae,4E. cloacae, and 4 Salmonella strains), whereas
CMY-2 (E. coli), SHV-2a (E. cloacae), SHV-44 (E. coli), a com-
binationofCTX-M-15andCMY-30(E.coli),andacombination
of CTX-M-15 and SHV-12 (K. pneumoniae) were found in 1
strain each.
Typable plasmidswere detected in 53%(9/17) of the acquired
CTX-M-15 E. coli strains. FII/FIA/FIB multireplicons were
found in 3, and FII/I1/Ic, FIA/FIB, and I1/Ic multireplicons in 2
each. MDR region markers were present in only 29% (5/17) of
the CTX-M-15 E. coli. No particular association between a
bacterial host genotype and a particular plasmid incompatibility
group was identiﬁed. Just as for those at admission, plasmids
from K. pneumoniae could not be typed.
Among the 17 acquired E. coli strains that produced CTX-M-15
( i s o l a t e df r o m1 4c h i l d r e n ) ,1 3c l u s t e r e do n l yi n4P F G Ep a t t e r n s
labeled B (5 strains), C (3 strains), D (3 strains), or F (2 strains).
Singletons were labeled (a), (b), or (c). Finally, 1 E. coli with PFGE
pattern H produced CTX-M-15 plus the plasmid-borne cepha-
losporinase CMY-30. Interestingly, 2 other E. coli strains with
PFGE pattern H were producing CMY-2 and SHV-44, re-
spectively. These PFGE patterns corresponded to ST354 for PFGE
patterns B and F, and to ST410, 101, 131, 617, 1284, and 216,
respectively, for patterns H, C, D and singleton strains (a), (b),
and (c) (Table 2). As stated earlier, ST354, 410, 101, and 131
were also identiﬁed at entry, suggesting that these clones were
circulating both inthe community and in thehospital. In contrast,
among the 11 CTX-M-15 K. pneumoniae strains, which were from
11 children, only 3 were grouped in 1 PFGE pattern, and the
others were singletons.
DISCUSSION
We showed that ESBL-E acquisition rate was dramatic during
hospitalization of children with severe acute malnutrition, al-
though they were discharged after a median of only 10 days.
Although thesample was small, which may limit the signiﬁcance
ofthe observation,theacquisition ratereached94%,higherthan
the already high 48% reported in a pediatric hospital in Ma-
dagascar [26]. Several factors may have contributed to the high
acquisition rate. First, the antibiotic exposure of the children
hospitalized in the Maradi center was massive and possibly fa-
cilitated acquisition. Indeed, many reports have shown the link
between b-lactam exposure and intestinal colonization by en-
terobacteria resistant to cephalosporins [27, 28]. This is worri-
some, because far from being administered without guidelines,
antibiotic regimens were chosen in accordance with WHO
recommendations for malnutrition cases [4]. Second, cross-
transmissionprobablyplayedarole,asevidencedbythefactthat
children from the renutrition center shared identical strains.
This was the case not only for K. pneumoniae strains, which are
well knownto be highly diffusible in an ICU setting [29, 30], but
also for E. coli, which is much less common, at least in hospitals
in developed countries [15, 31]. This cross-transmission was
probably favored by suboptimal hygiene and the high density of
patients in the center. We accumulated molecular evidence
Table 1 continued.
Characteristics
Inclusion in carriage study
Bivariate odds ratio (95% CI)
a P Adjusted P
b No (n 5 256) Yes (n 5 55)
Amoxicillin clavulanate
0 185 (72.3) 43 (78.2) 1.0 .84 1.00
1–3 20 (7.8) 3 (5.5) 0.6 (0.1–2.3)
4–8 46 (18.0) 9 (16.4) 0.8 (0.3–1.9)
$9 5 (2.0) 0 (0.0) 0.0 (0.0–4.9)
Ciproﬂoxacin
0 197 (77.0) 40 (72.7) 1.0 .40 1.00
1–3 9 (3.5) 3 (5.5) 1.6 (0.3–7.0)
4–8 47 (18.4) 10 (18.2) 1.0 (0.4–2.3)
$9 3 (1.2) 2 (3.6) 3.3 (0.3–29.4)
Gentamicin
0 249 (97.3) 52 (94.5) 1.0 .39 1.00
1–3 7 (2.7) 3 (5.5) 2.0 (0.3–9.3)
Where not otherwise speciﬁed, data represent no. (%) of patients.
a Bivariate analysis was performed using Pearson v
2, Fisher exact, Student’s t, and Wilcoxon tests (a 5 0.05). CI, conﬁdence interval.
b P after adjustment by Holm’s method [26, 27]
c One nonincluded child did not receive any antibiotic treatment.
Extended Spectrum b-Lactamase Carriage in a Renutrition Center d CID 2011:53 (1 October) d 681
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 Table 2. Microbiologic Characteristics of ESBL Strains
Time of isolation
and child
identiﬁcation no.
Strain
no.
Strain
characteristics
Resistance
characteristics
Species
PCR-based
pattern
PFGE
pattern
a
Escherichia
coli MLST
ESBL
type
Incompatibility
group
b
pC15-1a
type MDR
c
Admission
M145 1 Escherichia coli IX G 361 CTX-M-15 FIA/FIB Positive
M177 1 E. coli IX G 361 CTX-M-15 FIA/FIB Positive (DJ5)
M301 1 E. coli IX G 361 CTX-M-15 FIA/FIB Positive
M001 1 E. coli I ND 354 CTX-M-15 FIA/FIB Negative
M005 1 E. coli II ND 5 CTX-M-15 FII/I1/Ic Positive
(DJ6DblaTEM)
M009 1 E. coli III ND 131 CTX-M-15 FII/FIA Positive (DJ5)
M057 1 E. coli IV ND 10 CTX-M-15 NT Negative
M089 1 E. coli V ND 101 CTX-M-15 FII/I1/Ic Negative
M113 1 E. coli VI ND 68 CTX-M-15 FII/I1/Ic Negative
M113 2 E. coli VII ND 448 CTX-M-15 I1/Ic Negative
M125 1 E. coli VIII ND 196 CTX-M-15 NT Positive
M201 1 E. coli X ND 617 CTX-M-15 FIA/FIB Positive
(Dtet(A)DJ5)
M229 1 E. coli XI ND 410 CTX-M-15 NT Negative
M025 1 Klebsiella pneumoniae I ND NA SHV-2a ND ND
M141 1 K. pneumoniae II ND NA SHV-12 ND ND
M157 1 K. pneumoniae III ND NA CTX-M-15 NT Negative
M301 2 K. pneumoniae IV ND NA CTX-M-15 NT Negative
M009 2 Enterobacter cloacae ND ND NA CTX-M-15 ND ND
M125 2 E. cloacae ND ND NA CTX-M-15 ND ND
M141 2 E. cloacae ND ND NA CTX-M-15 ND ND
M217 1 E. cloacae ND ND NA CTX-M-15 ND ND
M213 1 Enterobacter asburiae ND ND NA CTX-M-15 ND ND
Discharge
M049 1 E. coli XIII F 354 CTX-M-15 FII/FIA/FIB Negative
M105 1 E. coli XIII B 354 CTX-M-15 FII/FIA/FIB Negative
M109 1 E. coli XIII B 354 CTX-M-15 I1/Ic Negative
M117 1 E. coli XIII B 354 CTX-M-15 FIA/FIB Negative
M121 1 E. coli XIII F 354 CTX-M-15 NT Negative
M129 1 E. coli XIII B 354 CTX-M-15 FII/I1/Ic Negative
M129 2 E. coli XIII B 354 CTX-M-15 FII/FIA/FIB Negative
M137 1 E. coli XV C 101 CTX-M-15 FII/I1/Ic Negative
M161 1 E. coli XV C 101 CTX-M-15 I1/Ic Negative
M165 1 E. coli XV C 101 CTX-M-15 NT Positive
M137 2 E. coli XVI D 131 CTX-M-15 NT Positive
M149 1 E. coli XVI D 131 CTX-M-15 TF Negative
M169 1 E. coli XVI D 131 CTX-M-15 FIA/FIB Positive
M105 2 E. coli XIV H 410 CMY-2 ND ND
M221 2 E. coli XIV H 410 SHV-44 ND ND
M237 1 E. coli XIV H 410 CTX-M-15 1 CMY-30 NT Negative
M169 2 E. coli XVI S (a) 617 CTX-M-15 NT Negative
M193 1 E. coli XVII S (b) 1284 CTX-M-15 NT Positive
M233 1 E. coli XVIII S (c) 216 CTX-M-15 NT Positive
M117 2 K. pneumoniae V A NA CTX-M-15 NT Negative
M121 2 K. pneumoniae V A NA CTX-M-15 NT Negative
M193 2 K. pneumoniae V A NA CTX-M-15 1 SHV-12 NT Negative
682 d CID 2011:53 (1 October) d Woerther et al
 
b
y
 
g
u
e
s
t
 
o
n
 
S
e
p
t
e
m
b
e
r
 
6
,
 
2
0
1
1
c
i
d
.
o
x
f
o
r
d
j
o
u
r
n
a
l
s
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 that transmission of a few clones of CTX-M-15 E. coli was re-
sponsible for acquisition in most cases. MLST showed that they
were grouped in a small number of ST types, namely, ST354,
ST101, and ST131, which were not only carried by children at
admission but also acquired in the center. These 3 E. coli ST
types have been found to predominate among E. coli CTX-M
clinical isolates elsewhere and are considered highly virulent
[32]. Here, we showed that they are also good gut colonizers
with high potential for nosocomial dissemination.
We also observed that some children were colonized with
CTX-M-15 E. coli belonging to the less studied ST617, 1284,
410, and 216 clones, suggesting that gene exchange was intense
between strains. This was further conﬁrmed by plasmid char-
acterization. A minimum of 5 CTX-M-15–carrying plasmids,
identiﬁed by replicon typing, were identiﬁed among the 7 ac-
quired ST354 E. coli strains. In the same way, the 3 acquired
ST410 E. coli strains were found in association with 3 different
ESBL enzymes. We also conﬁrmed the previously suggested role
of IncF plasmids, known to be associated with E. coli,i nt h e
dissemination of blaCTX-M-15, which has been described else-
where [23]. Besides plasmids, gene exchange was also evidenced
by our identiﬁcation in E. coli strains, both at entry and at
discharge, of MDR blaCTX-M-15 genetic environments similar to
that of plasmid pC15-1a, described in communities worldwide,
particularly from several African countries [14, 33, 34]. It is
suspected to have a major role in the worldwide dissemination
of CTX-M-15. None of these features was observed in K.
pneumoniae strains, suggesting that other means of dissemina-
tion of blaCTX-M-15 exist for that species.
Cross-transmission of resistant ESBL-E in ICUs can be
prevented only by implementing strict control measures. In
developed countries, recommendations for the control of cross-
contamination include increased ratios of paramedical workers
to patients (at least triple the ratios of the renutrition center)
[35] along with screening for rectal colonization. Widespread
use of alcohol-based hand rub solution, recently promoted by
WHO as the single most efﬁcient measure for safety of care [36],
is also recommended and can be applied in developing countries.
Indeed, WHO provides recipes for preparing such solutions easily
(WHO Guidelines on Hand Hygiene in Health Care, http://
whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf).
Documenting whether colonization was followed by clinical in-
fection was beyond the scope of the study, but it has been
demonstrated repeatedly in the past [37–39].Itisalsoknownthat
children area key ESBL-E reservoir [40]. Thus, we believe that the
dramatic colonization rate observed in the Maradi center, in
addition to providing a source of infection for the hospitalized
children, may also contribute to ESBL-E dissemination, not
Table 2 continued.
Time of isolation
and child
identiﬁcation no.
Strain
no.
Strain
characteristics
Resistance
characteristics
Species
PCR-based
pattern
PFGE
pattern
a
Escherichia
coli MLST
ESBL
type
Incompatibility
group
b
pC15-1a
type MDR
c
M109 2 K. pneumoniae III S NA CTX-M-15 TF Negative
M137 3 K. pneumoniae VI S NA CTX-M-15 NT Negative
M149 2 K. pneumoniae VI S NA CTX-M-15 NT Negative
M161 2 K. pneumoniae VII S NA CTX-M-15 NT Positive (Dtet(A))
M165 2 K. pneumoniae VII S NA CTX-M-15 NT Positive
(DJ2Dtet(A)DJ5)
M169 3 K. pneumoniae VI S NA CTX-M-15 NT Negative
M221 1 K. pneumoniae V S NA CTX-M-15 NT Negative
M237 2 K. pneumoniae V S NA CTX-M-15 NT Negative
M049 2 E. cloacae ND ND NA CTX-M-15 ND ND
M117 3 E. cloacae ND ND NA SVH-2a ND ND
M149 3 E. cloacae ND ND NA CTX-M-15 ND ND
M233 2 E. cloacae ND ND NA CTX-M-15 ND ND
M237 3 E. cloacae ND ND NA CTX-M-15 ND ND
M161 3 Salmonella Typhimurium ND ND NA CTX-M-15 ND ND
M165 3 S. Typhimurium ND ND NA CTX-M-15 ND ND
M233 3 S. Typhimurium ND ND NA CTX-M-15 ND ND
M237 4 S. Typhimurium ND ND NA CTX-M-15 ND ND
Abbreviations: ESBL, extended-spectrum b-lactamase–producing; NA, not applicable; ND, not done; PCR, polymerase chain reaction; PFGE, pulsed-ﬁeld gel
electrophoresis.
a The E. coli and K. pneumoniae clones ($2 strains) are named A, B, C, D, E, F, G, and H, according to PFGE patterns. S indicates singletons (strains with unique
PFGE pattern); E. coli singletons were named (a), (b), and (c).
b NT indicates that the plasmid was not typable; TF, that the transfer in the E. coli recipient failed.
c Multidrug resistance (MDR) region analogous to that of the pC15-1a plasmid was considered present (positive) when $10/13 of the mapping PCR performed
were positive and otherwise were considered absent (negative); deletions are in parentheses.
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 only in the renutrition center but also in the community after
discharge [41] .W h e nt h ec h o i c eo fa n t i b i o t i c si sn a r r o w e dt o
carbapenems, consequences of that dissemination may be of
extreme concern, especially in developing countries, where these
treatments are not usually available. Although our study was only
descriptive, its results are a strong incentive to review the beneﬁt–
risk ratios of current antibiotic policies in children with severe
acute malnutrition, given the concerns associated with the future
of antibiotics and the current dissemination of carbapenemase-
producing enterobacteria, which appear to follow the same paths
as ESBL-E [42].
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